Ravi Amaravadi
University of Pennsylvania
H-index: 78
North America-United States
Top articles of Ravi Amaravadi
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Corrigendum to'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma':[Annals of Oncology … | Annals of oncology: official journal of the European Society for Medical Oncology | CE Sharon GN Tortorello KL Ma AC Huang X Xu | 2024/4/13 |
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Nature communications | Cathrine Axfors Andreas M Schmitt Perrine Janiaud Janneke van’t Hooft Sherief Abd-Elsalam | 2024/2/5 |
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma | Clinical Cancer Research | Thomas M Anderson Bryan H Chang Alexander C Huang Xiaowei Xu Daniel Yoon | 2024/1/24 |
Targeting UGCG overcomes resistance to lysosomal autophagy inhibition | Cancer discovery | Vaibhav Jain Sandra L Harper Amanda M Versace Dylan Fingerman Gregory Schuyler Brown | 2023/2/6 |
579-C Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade | Kevin Wang Paulina Coutifaris David Brocks Sabrina Solis Nicholas Han | 2023/11/1 | |
Five-year survival outcomes in patients with melanoma with complete response to immunotherapy who discontinue therapy. | Benjamin Aaron Bleiberg Phyllis A Gimotty Alex Mathew Grayce Selig Ahron Flowers | 2023/6/1 | |
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity | Cell reports | Wenqun Zhong Youtao Lu Xuexiang Han Jingbo Yang Zhiyuan Qin | 2023/10/31 |
Patient-derived melanoma organoid models facilitate the assessment of immunotherapies | EBioMedicine | Lingling Ou Shujing Liu Huaishan Wang Yeye Guo Lei Guan | 2023/6/1 |
Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma | Annals of Oncology | CE Sharon GN Tortorello KL Ma AC Huang X Xu | 2023/9/1 |
Phase I trial of autologous RNA-electroporated cMET-directed CAR T cells administered intravenously in patients with melanoma and breast carcinoma | Cancer Research Communications | Payal D Shah Alexander C Huang Xiaowei Xu Robert Orlowski Ravi K Amaravadi | 2023/5/9 |
Lysosomal lipid peroxidation regulates tumor immunity | The Journal of Clinical Investigation | Monika Bhardwaj Jennifer J Lee Amanda M Versace Sandra L Harper Aaron R Goldman | 2023/4/17 |
HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation | Cell reports | Wei Zhang Jiegang Yang Beike Wang Youtao Lu Jingbo Yang | 2023/11/28 |
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer | The Oncologist | Charu Aggarwal Alisha P Maity Joshua M Bauml Qi Long Tomas Aleman | 2023/7/1 |
Recent advances in targeting autophagy in cancer | Vaibhav Jain Mahendra Pal Singh Ravi K Amaravadi | 2023/3/15 | |
20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma research | Ravi Amaravadi Andrew Aplin Meenhard Herlyn Sheri Holmen Richard White | 2023/11 | |
Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials | Hwanhee Hong Anne Friedland Mengyi Hu Kevin J Anstrom Susan Halabi | 2023/6/1 | |
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant … | Clinical Cancer Research | Janice M Mehnert Tara C Mitchell Alexander C Huang Tomas S Aleman Benjamin J Kim | 2022/3/15 |
Pumping iron: ferritinophagy promotes survival and therapy resistance in pancreatic cancer | Cancer discovery | Vaibhav Jain Ravi K Amaravadi | 2022/9/2 |
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors | Nature communications | Lei Guan Bin Wu Ting Li Lynn A Beer Gaurav Sharma | 2022/7/14 |
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers | Immunity | Josephine R Giles Sasikanth Manne Elizabeth Freilich Derek A Oldridge Amy E Baxter | 2022/3/8 |